Evidence map›Paper›PMID 22314249›Full record

ArticleChinese medicine2012

Ginsenoside Re: Its chemistry, metabolism and pharmacokinetics.

Dacheng Peng, Huashan Wang, Chenling Qu, Laihua Xie, Sheila M Wicks, Jingtian Xie

Abstract read
In one paragraph

Article in Chinese medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Ginsenoside Rb1 From the Functional FoodFood science & nutrition · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Bioactive Compounds and Their Influence on Postnatal Neurogenesis.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Article
  13. Review
  14. Pharmacological Properties of Ginsenoside Re.Frontiers in pharmacology · 2022
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Analysis of the Rule of TCM Compatibility in TCM Prescriptions ContainingEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dacheng PengThe Ben May Department for Cancer Research, Pritzker School of Medicine, The University of Chicago, Chicago, IL 60637, USA. xiela@umdnj.edu.
Huashan Wang
Chenling Qu
Laihua Xie
Sheila M Wicks
Jingtian Xie

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ginsenosides, the bioactive components of ginseng, can be divided into two major groups, namely 20(S)-protopanaxatriol (e.g. Re, Rg1, Rg2, and Rb3) and 20(S)-protopanaxadiol (e.g. Rb1, Rb2, Rc, and Rd). Biological and environmental factors may affect the content of ginsenosides in different parts of ginseng plant. Evidence from pharmacokinetic and metabolic studies of Re demonstrated that (1) the absorption of Re is fast in gastrointestinal tract; (2) Re may be metabolized mainly to Rh1 and F1 by intestinal microflora before absorption into blood; and (3) Re is quickly cleared from the body.

Identifiers

PMID22314249
PMCPMC3296575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.